pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jun 18·1 min read
save

Super-potent nitazene opioids linked to sharp rise in U.S. overdose deaths

Jun 18, 2026·read at STAT ↗Negative

Synthetic opioids known as nitazenes, which can be up to forty times stronger than fentanyl, are increasingly being found mixed into other street drugs across the United States.

The Centers for Disease Control and Prevention reports that deaths involving nitazenes have jumped from 27 in 2020 to 409 in 2024, indicating a rapid and alarming spread of the substance.

A personal case highlighted in the reporting describes Ashley Delgado, a former prescription‑opioid patient whose addiction progressed to fentanyl and ultimately to nitazene exposure, leading to her death in 2023.

The surge underscores growing challenges for public‑health officials and underscores the need for enhanced surveillance and intervention strategies to curb the emerging crisis.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Super-potent synthetic opioids called nitazenes are spreading across the U.S.”

read at STAT ↗
2,800 words · retrieved Jun 18
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
LEADINGRISINGUNIQUE
drugs
FENTANYL-3718FENTANYL-7518fentanyl18fentanyl CR18fentanyl ER18OXYCODONE HYDROCHLORIDEOXYCONTINXTAMPZA ERnaloxoneoxycodone ER
topics
Epilepsy3GLP-1 receptorObesityOncologyVaccine

related stories

  • May 13U.S. overdose deaths fell again in 2025, but some worry about policy and drug supply changesSTAT
  • Jun 18New infant botulism outbreak puts fancy formulas under scrutinySTAT
  • Apr 27New U.S. recommendation on hepatitis B vaccine will have dire consequences, studies projectSTAT
  • Aug 27A state gave sheriffs 20% of its opioid settlement cash. We followed the moneySTAT
  • Jul 31Syphilis spreads while researchers contend with federal constraints and a drug shortageSTAT